CVRx CEO Nadim Yared described the Barostim Neo system as the first device to use the brain and nervous system to target cardiovascular disease. (Pixabay)
The FDA approved a new device for people suffering from advanced heart failure who are not able to receive treatment from other devices, such as cardiac resynchronization therapy.
